Research Article
BibTex RIS Cite

Ailesel Akdeniz Ateşi Olan Hastalarda Nazal Mukosiliyer Aktivitenin Değerlendirilmesi

Year 2021, , 55 - 59, 11.03.2021
https://doi.org/10.18521/ktd.793301

Abstract

Amaç: Bu çalışmanın amacı Ailesel Akdeniz Ateşi (AAA) hastalarında anterior rinomanometre ve sakarin test kullanılarak nazal hava yolu direncini ve nazal mukosiliyer aktiviteyi değerlendirmektir.

Gereç ve Yöntem: Bu prospektif, kesitsel çalışmaya AAA hastalığı olan 30 hasta ve 30 sağlıklı birey dahil edildi. Tüm katılımcılara nazal hava yolu direncini ölçmek için aktif anterior rinomanometre ve nazal mukosiliyer klerens zamanını ölçmek için sakarin test uygulandı.

Bulgular: AAA hasta grubu ve kontrol gruplarında ortalama nazal mukosiliyer klerens zamanı sırasıyla 14.6 ± 4.7 (aralık, 8-30) dk. ve 9,7 ± 2,3 (aralık, 6-14) dk. olarak saptandı. AAA hastalarında nazal mukosiliyer klerens zamanı sağlıklı kontrollere göre anlamlı olarak uzundu ( p <0.001). Nazal mukosiliyer klerens zamanı ile hastalık süresi arasında istatistiksel olarak anlamlı bir korelasyon tespit etmedik ( p <0.001, r=0.019). Her iki grubun ortalama nazal hava yolu direnci değerleri karşılaştırıldığında, anlamlı bir fark saptanmadı (p=0.371).

Sonuç: Çalışmamızın sonuçları, AAA hastalarında nazal mukosiliyer klerens zamanının sağlıklı kontrollere göre daha uzun olduğunu ortaya koymuştur. Bununla birlikte, nazal mukosiliyer klerens süresi ve hastalık süresi arasında istatistiksel olarak anlamlı bir korelasyon yoktu. Nazal mukosiliyer klerensin bozulması, üst ve alt solunum yollarında enfeksiyon riskini artırır. AAA hastalarında üst ve alt solunum yolu enfeksiyonlarına karşı dikkatli olunmalıdır.

References

  • 1. Onen F, Sumer H, Turkay S, Akyurek O, Tunca M, Ozdogan H. Increased frequency of familial Mediterranean fever in Central Anatolia, Turkey. Clin Exp Rheumatol. 2004; 22:31-3
  • 2. Ahsen A, Ulu MS, Yuksel S, Demir K, Uysal M, Erdogan M, et al. As a new inflammatory marker for familial mediterranean fever: Neutrophil-to-lymphocyte ratio. Inflammation. 2013; 36(6):1357-62
  • 3. Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum. 1997; 40(10):1879-85
  • 4. Berkun Y, Eisenstein EM. Diagnostic criteria of familial Mediterranean fever. Autoimmunity Reviews. 2014;13(4-5):388-90
  • 5. Lachmann HJ, Şengül B, Yavuzşen TU, Booth DR, Booth SE, Bybee A, et al. Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology. 2006;45(6):746-750
  • 6. Aroor R, Sunu Ali Z, Gangadhara Somayaji KS. Do Nasal Surgeries Affect Mucociliary Clearance? Indian J Otolaryngol Head Neck Surg. 2017;69(1):24-28
  • 7. Gudis D, Zhao KQ, Cohen NA. Acquired cilia dysfunction in chronic rhinosinusitis. American Journal of Rhinology and Allergy. 2012; 26(1):1-6
  • 8. Cohen NA. Sinonasal mucociliary clearance in health and disease. Annals of Otology, Rhinology and Laryngology. 2006;196:20-6
  • 9. Utiyama DMO, Yoshida CT, Goto DM, Carvalho T de S, Santos UDP, Koczulla AR, et al. The effects of smoking and smoking cessation on nasal mucociliary clearance, mucus properties and inflammation. Clinics. 2016;71(6):344-50
  • 10. Demirbas D, Cingi C, Cakli H, Kaya E. Use of rhinomanometry in common rhinologic disorders. Expert Rev Med Devices. 2011;8(6):769-777
  • 11. Corey J, Pallanch J. Evaluation of Nasal Breathing Function with Objective Airway Testing. In: Cummings Otolaryngology - Head and Neck Surgery. 2010.
  • 12. Gangemi S, Manti S, Procopio V, Casciaro M, Di Salvo E, Cutrupi M, et al. Lack of clear and univocal genotype-phenotype correlation in familial Mediterranean fever patients: A systematic review. Clinical Genetics. 2018;94(1):81-94
  • 13. Bagci S, Toy B, Tuzun A, Ates Y, Aslan M, Inal A, et al. Continuity of cytokine activation in patients with familial Mediterranean fever. Clin Rheumatol. 2004;23:333-7
  • 14. Yildirim K, Uzkeser H, Keles M, Karatay S, Kiziltunc A, Kaya MD, et al. Relationship between serum interleukin-1β levels and acute phase response proteins in patients with familial Mediterranean fever. Biochem Medica. 2012;30: 305– 308
  • 15. Laoukili J, Perret E, Willems T, Minty A, Parthoens E, Houcine O, et al. IL-13 alters mucociliary differentiation and ciliary beating of human respiratory epithelial cells. J Clin Invest. 2001;108(12):1817-24
  • 16. González C, Droguett K, Rios M, Cohen NA, Villalón M. TNF α Affects Ciliary Beat Response to Increased Viscosity in Human Pediatric Airway Epithelium. Biomed Res Int. 2016;3628501
  • 17. Rhee CS, Hong SK, Min YG, Lee CH, Lee KS, Ahn SH, et al. Effects of il-1β, TNF-α, and tgf-β on ciliary beat frequency of human nasal ciliated epithelial cells in vitro. Am J Rhinol. 1999; 1999;13(1):27-30
  • 18. Guan W jie, Peng Y, Zi X xue, Tan K Sen, He T ting, Zhong N shan, et al. Motile Ciliary Disorders in Chronic Airway Inflammatory Diseases: Critical Target for Interventions. Current Allergy and Asthma Reports. 2018;18(9):48
  • 19. Yengil E, Cevik C, Silfeler I, Yula E, Kurtoglu IA, Arica V, et al. Higher frequency of methicillin resistant bacteria in children with familial mediterranean fever. J Pak Med Assoc. 2015;65(2):196-200
  • 20. Brik R, Gershoni-Baruch R, Shinawi M, Barak L, Bentur L. Pulmonary manifestations and function tests in children genetically diagnosed with FMF. Pediatr Pulmonol. 2003;35(6):452-5
  • 21. Celiksoy MH, Dogan C, Erturk B, Keskin E, Ada BS. The MEFV gene and its association with familial Mediterranean fever, severe atopy, and recurrent respiratory tract infections [published online ahead of print, 2020 Apr 28]. Allergol Immunopathol (Madr). doi:10.1016/j.aller.2019.12.010
  • 22. Ozdogan H, Arisoy N, Kasapçapur O, Sever L, Çalişkan S, Tuzuner N, et al. Vasculitis in familial Mediterranean fever. J Rheumatol. 1997;24(2):323-327
  • 23. Schwartz T, Langevitz P, Zemer D, Gazit E, Pras M, Livneh A. Behcet’s disease in Familial Mediterranean fever: Characterization of the association between the two diseases. Semin Arthritis Rheum. 2000; 2000;29(5):286-95
  • 24. Watad A, Tiosano S, Yahav D, Comaneshter D, Shoenfeld Y, Cohen AD, et al. Behçet’s disease‬ and familial Mediterranean fever: Two sides of the same coin or just an association? A cross-sectional study‬. Eur J Intern Med. 2017;39:75-78
  • 25. Ozbay I, Kucur C, Temizturk F, Ozkan Y, Kahraman C, Oghan F. Assessment of nasal mucociliary activity in patients with Behçet’s disease. J Laryngol Otol. 2016; 130(4):348-351.

Evaluation of Nasal Mucociliary Activity in Patients with Familial Mediterranean Fever

Year 2021, , 55 - 59, 11.03.2021
https://doi.org/10.18521/ktd.793301

Abstract

Objective: The aim of this study was to evaluate nasal airway resistance and nasal mucociliary activity in Familial Mediterranean Fever (FMF) patients using anterior rhinomanometry and saccharin clearance test.

Methods: 30 patients with FMF disease and 30 healthy individuals were included in this prospective, cross-sectional study. Nasal airway resistance was measured via active anterior rhinomanometry and a saccharin test was carried out for the measurement of nasal mucociliary clearance (NMC) times of all participants.

Results: Mean values for NMC time in the FMF patient group and control group were found as 14.6 ± 4.7 (range, 8-30) min. and 9.7 ± 2.3 (range, 6-14) min. respectively. Nasal mucociliary clearance time in the FMF patients was significantly prolonged in comparison to that of healthy controls (p < 0.001). We identified no significant correlation between the disease duration and NMC time (p=0.921, r = 0.019). When the mean nasal airway resistance values of both groups were compared, there was no significant difference was detected (p = 0.371).

Conclusion: The results of our study have revealed that NMC time was longer in patients with FMF than healthy controls. However, there was no statistically significant correlation between nasal mucociliary clearance time and disease duration. Disruption of NMC increases the risk of infection in the upper and lower respiratory tract. Caution should be exercised against upper and lower respiratory infections in patients with FMF.

References

  • 1. Onen F, Sumer H, Turkay S, Akyurek O, Tunca M, Ozdogan H. Increased frequency of familial Mediterranean fever in Central Anatolia, Turkey. Clin Exp Rheumatol. 2004; 22:31-3
  • 2. Ahsen A, Ulu MS, Yuksel S, Demir K, Uysal M, Erdogan M, et al. As a new inflammatory marker for familial mediterranean fever: Neutrophil-to-lymphocyte ratio. Inflammation. 2013; 36(6):1357-62
  • 3. Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum. 1997; 40(10):1879-85
  • 4. Berkun Y, Eisenstein EM. Diagnostic criteria of familial Mediterranean fever. Autoimmunity Reviews. 2014;13(4-5):388-90
  • 5. Lachmann HJ, Şengül B, Yavuzşen TU, Booth DR, Booth SE, Bybee A, et al. Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology. 2006;45(6):746-750
  • 6. Aroor R, Sunu Ali Z, Gangadhara Somayaji KS. Do Nasal Surgeries Affect Mucociliary Clearance? Indian J Otolaryngol Head Neck Surg. 2017;69(1):24-28
  • 7. Gudis D, Zhao KQ, Cohen NA. Acquired cilia dysfunction in chronic rhinosinusitis. American Journal of Rhinology and Allergy. 2012; 26(1):1-6
  • 8. Cohen NA. Sinonasal mucociliary clearance in health and disease. Annals of Otology, Rhinology and Laryngology. 2006;196:20-6
  • 9. Utiyama DMO, Yoshida CT, Goto DM, Carvalho T de S, Santos UDP, Koczulla AR, et al. The effects of smoking and smoking cessation on nasal mucociliary clearance, mucus properties and inflammation. Clinics. 2016;71(6):344-50
  • 10. Demirbas D, Cingi C, Cakli H, Kaya E. Use of rhinomanometry in common rhinologic disorders. Expert Rev Med Devices. 2011;8(6):769-777
  • 11. Corey J, Pallanch J. Evaluation of Nasal Breathing Function with Objective Airway Testing. In: Cummings Otolaryngology - Head and Neck Surgery. 2010.
  • 12. Gangemi S, Manti S, Procopio V, Casciaro M, Di Salvo E, Cutrupi M, et al. Lack of clear and univocal genotype-phenotype correlation in familial Mediterranean fever patients: A systematic review. Clinical Genetics. 2018;94(1):81-94
  • 13. Bagci S, Toy B, Tuzun A, Ates Y, Aslan M, Inal A, et al. Continuity of cytokine activation in patients with familial Mediterranean fever. Clin Rheumatol. 2004;23:333-7
  • 14. Yildirim K, Uzkeser H, Keles M, Karatay S, Kiziltunc A, Kaya MD, et al. Relationship between serum interleukin-1β levels and acute phase response proteins in patients with familial Mediterranean fever. Biochem Medica. 2012;30: 305– 308
  • 15. Laoukili J, Perret E, Willems T, Minty A, Parthoens E, Houcine O, et al. IL-13 alters mucociliary differentiation and ciliary beating of human respiratory epithelial cells. J Clin Invest. 2001;108(12):1817-24
  • 16. González C, Droguett K, Rios M, Cohen NA, Villalón M. TNF α Affects Ciliary Beat Response to Increased Viscosity in Human Pediatric Airway Epithelium. Biomed Res Int. 2016;3628501
  • 17. Rhee CS, Hong SK, Min YG, Lee CH, Lee KS, Ahn SH, et al. Effects of il-1β, TNF-α, and tgf-β on ciliary beat frequency of human nasal ciliated epithelial cells in vitro. Am J Rhinol. 1999; 1999;13(1):27-30
  • 18. Guan W jie, Peng Y, Zi X xue, Tan K Sen, He T ting, Zhong N shan, et al. Motile Ciliary Disorders in Chronic Airway Inflammatory Diseases: Critical Target for Interventions. Current Allergy and Asthma Reports. 2018;18(9):48
  • 19. Yengil E, Cevik C, Silfeler I, Yula E, Kurtoglu IA, Arica V, et al. Higher frequency of methicillin resistant bacteria in children with familial mediterranean fever. J Pak Med Assoc. 2015;65(2):196-200
  • 20. Brik R, Gershoni-Baruch R, Shinawi M, Barak L, Bentur L. Pulmonary manifestations and function tests in children genetically diagnosed with FMF. Pediatr Pulmonol. 2003;35(6):452-5
  • 21. Celiksoy MH, Dogan C, Erturk B, Keskin E, Ada BS. The MEFV gene and its association with familial Mediterranean fever, severe atopy, and recurrent respiratory tract infections [published online ahead of print, 2020 Apr 28]. Allergol Immunopathol (Madr). doi:10.1016/j.aller.2019.12.010
  • 22. Ozdogan H, Arisoy N, Kasapçapur O, Sever L, Çalişkan S, Tuzuner N, et al. Vasculitis in familial Mediterranean fever. J Rheumatol. 1997;24(2):323-327
  • 23. Schwartz T, Langevitz P, Zemer D, Gazit E, Pras M, Livneh A. Behcet’s disease in Familial Mediterranean fever: Characterization of the association between the two diseases. Semin Arthritis Rheum. 2000; 2000;29(5):286-95
  • 24. Watad A, Tiosano S, Yahav D, Comaneshter D, Shoenfeld Y, Cohen AD, et al. Behçet’s disease‬ and familial Mediterranean fever: Two sides of the same coin or just an association? A cross-sectional study‬. Eur J Intern Med. 2017;39:75-78
  • 25. Ozbay I, Kucur C, Temizturk F, Ozkan Y, Kahraman C, Oghan F. Assessment of nasal mucociliary activity in patients with Behçet’s disease. J Laryngol Otol. 2016; 130(4):348-351.
There are 25 citations in total.

Details

Primary Language English
Subjects Health Care Administration
Journal Section Articles
Authors

Elif Karalı 0000-0002-8164-4056

Muhammed Emin Demirkol 0000-0001-9554-8922

Akif Güneş 0000-0003-3965-7360

Müjgan Gürler 0000-0001-8777-9077

Publication Date March 11, 2021
Acceptance Date November 10, 2020
Published in Issue Year 2021

Cite

APA Karalı, E., Demirkol, M. E., Güneş, A., Gürler, M. (2021). Evaluation of Nasal Mucociliary Activity in Patients with Familial Mediterranean Fever. Konuralp Medical Journal, 13(1), 55-59. https://doi.org/10.18521/ktd.793301
AMA Karalı E, Demirkol ME, Güneş A, Gürler M. Evaluation of Nasal Mucociliary Activity in Patients with Familial Mediterranean Fever. Konuralp Medical Journal. March 2021;13(1):55-59. doi:10.18521/ktd.793301
Chicago Karalı, Elif, Muhammed Emin Demirkol, Akif Güneş, and Müjgan Gürler. “Evaluation of Nasal Mucociliary Activity in Patients With Familial Mediterranean Fever”. Konuralp Medical Journal 13, no. 1 (March 2021): 55-59. https://doi.org/10.18521/ktd.793301.
EndNote Karalı E, Demirkol ME, Güneş A, Gürler M (March 1, 2021) Evaluation of Nasal Mucociliary Activity in Patients with Familial Mediterranean Fever. Konuralp Medical Journal 13 1 55–59.
IEEE E. Karalı, M. E. Demirkol, A. Güneş, and M. Gürler, “Evaluation of Nasal Mucociliary Activity in Patients with Familial Mediterranean Fever”, Konuralp Medical Journal, vol. 13, no. 1, pp. 55–59, 2021, doi: 10.18521/ktd.793301.
ISNAD Karalı, Elif et al. “Evaluation of Nasal Mucociliary Activity in Patients With Familial Mediterranean Fever”. Konuralp Medical Journal 13/1 (March 2021), 55-59. https://doi.org/10.18521/ktd.793301.
JAMA Karalı E, Demirkol ME, Güneş A, Gürler M. Evaluation of Nasal Mucociliary Activity in Patients with Familial Mediterranean Fever. Konuralp Medical Journal. 2021;13:55–59.
MLA Karalı, Elif et al. “Evaluation of Nasal Mucociliary Activity in Patients With Familial Mediterranean Fever”. Konuralp Medical Journal, vol. 13, no. 1, 2021, pp. 55-59, doi:10.18521/ktd.793301.
Vancouver Karalı E, Demirkol ME, Güneş A, Gürler M. Evaluation of Nasal Mucociliary Activity in Patients with Familial Mediterranean Fever. Konuralp Medical Journal. 2021;13(1):55-9.